Injectable Fibrin Scaffold Improves Cell Transplant Survival, Reduces Infarct Expansion, and Induces Neovasculature Formation in Ischemic Myocardium

Ghostine, 2002, Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction, Circulation, 106, I131, 10.1161/01.cir.0000032889.55215.f1 Gojo, 1997, Transplantation of genetically marked cardiac muscle cells, J Thorac Cardiovasc Surg, 113, 10, 10.1016/S0022-5223(97)70394-5 Jain, 2001, Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction, Circulation, 103, 1920, 10.1161/01.CIR.103.14.1920 Li, 1996, Cardiomyocyte transplantation improves heart function, Ann Thorac Surg, 62, 654, 10.1016/S0003-4975(96)00389-X Muller-Ehmsen, 2002, Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium, J Mol Cell Cardiol, 34, 107, 10.1006/jmcc.2001.1491 Orlic, 2001, Bone marrow cells regenerate infarcted myocardium, Nature, 410, 701, 10.1038/35070587 Reinecke, 1999, Survival, integration, and differentiation of cardiomyocyte grafts, Circulation, 100, 193, 10.1161/01.CIR.100.2.193 Reinecke, 2000, Transmural replacement of myocardium after skeletal myoblast grafting into the heart. Too much of a good thing?, Cardiovasc Pathol, 9, 337, 10.1016/S1054-8807(00)00055-7 Sakai, 1999, Fetal cell transplantation, J Thorac Cardiovasc Surg, 118, 715, 10.1016/S0022-5223(99)70018-8 Scorsin, 1997, Does transplantation of cardiomyocytes improve function of infarcted myocardium?, Circulation, 96, II-188 Zhang, 2001, Cardiomyocyte grafting for cardiac repair, J Mol Cell Cardiol, 33, 907, 10.1006/jmcc.2001.1367 Reinecke, 2002, Taking the death toll after cardiomyocyte grafting, J Mol Cell Cardiol, 34, 251, 10.1006/jmcc.2001.1494 Leor, 2000, Bioengineered cardiac grafts, Circulation, 102, III56, 10.1161/01.CIR.102.suppl_3.III-56 Kellar, 2001, Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue, Circulation, 104, 2063, 10.1161/hc4201.097192 Thompson, 1992, Angiogenic activity of fibrin degradation products is located in fibrin fragment E, J Pathol, 168, 47, 10.1002/path.1711680109 Bootle-Wilbraham, 2001, Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro, Angiogenesis, 4, 269, 10.1023/A:1016076121918 Naito, 2000, Smooth muscle cell outgrowth stimulated by fibrin degradation products. The potential role of fibrin fragment E in restenosis and atherogenesis, Thromb Res, 98, 165, 10.1016/S0049-3848(99)00202-9 Dvorak, 1987, Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing, Lab Invest, 57, 673 Christman, 2004, Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction, Tissue Eng, 10, 403, 10.1089/107632704323061762 Sievers, 1989, A model of acute regional myocardial ischemia and reperfusion in the rat, Magn Reson Med, 10, 172, 10.1002/mrm.1910100203 Wolfe, 1989, Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy, Circulation, 80, 969, 10.1161/01.CIR.80.4.969 Zhu, 2000, Comparative effects of pretreatment with captopril and losartan on cardiovascular protection in a rat model of ischemia-reperfusion, J Am Coll Cardiol, 35, 787, 10.1016/S0735-1097(99)00592-6 Zhu, 2001, Effects of different durations of pretreatment with losartan on myocardial infarct size, endothelial function, and vascular endothelial growth factor, J Renin Angiotensin Aldosterone Syst, 2, 129, 10.3317/jraas.2001.014 Rando, 1994, Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy, J Cell Biol, 125, 1275, 10.1083/jcb.125.6.1275 Fishbein, 1978, Experimental myocardial infarction in the rat, Am J Pathol, 90, 57 Kloner, 2000, Intramyocardial injection of DNA encoding vascular endothelial growth factor in a myocardial infarction model, J Thromb Thrombolysis, 10, 285, 10.1023/A:1026507627097 Li, 2003, Role of MMPs and plasminogen activators in angiogenesis after transmyocardial laser revascularization in dogs, Am J Physiol Heart Circ Physiol, 284, H23, 10.1152/ajpheart.00240.2002 Havenith, 1990, Muscle fiber typing in routinely processed skeletal muscle with monoclonal antibodies, Histochemistry, 93, 497, 10.1007/BF00266407 Tambara, 2003, Transplanted skeletal myoblasts can fully replace the infarcted myocardium when they survive in the host in large numbers, Circulation, 108, II259 Sierra, 1993, Fibrin sealant adhesive systems, J Biomater Appl, 7, 309, 10.1177/088532829300700402 Seelich, 1982, Biochemistry and methods of application, J Head Neck Pathol, 365 Benjamin, 1998, A plasticity window for blood vessel remodeling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF, Development, 125, 1591, 10.1242/dev.125.9.1591 Thiagarajan, 1996, Alternative adhesion sites in human fibrinogen for vascular endothelial cells, Biochemistry, 35, 4169, 10.1021/bi952532b Vailhe, 1997, In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to alpha(v)beta3 integrin localization, In Vitro Cell Dev Biol Anim, 33, 763, 10.1007/s11626-997-0155-6 Bach, 1998, VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels, Exp Cell Res, 238, 324, 10.1006/excr.1997.3844 Sahni, 1998, Binding of basic fibroblast growth factor to fibrinogen and fibrin, J Biol Chem, 273, 7554, 10.1074/jbc.273.13.7554 Harrison, 1993, Platelet alpha-granules, Blood Rev, 7, 52, 10.1016/0268-960X(93)90024-X Radosevich, 1997, Fibrin sealant, Vox Sang, 72, 133, 10.1046/j.1423-0410.1997.7230133.x